https://www.edhacare.com/treat....ments/cancer/car-t-c
Understanding The Success Of CAR T-Cell Therapy In Multiple Myeloma
The treatment of multiple myeloma, a bone marrow malignancy, has been transformed by CAR T-cell therapy, especially for patients who have not responded to traditional medicines. This immunotherapy targets the B-cell maturation antigen (BCMA) present on myeloma cells by altering the patient's T-cells to express chimeric antigen receptors (CARs).
Like
Comment
Share
